These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15052774)

  • 21. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
    Rotman HL; Daly TM; Long CA
    Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.
    Sauzet JP; Perlaza BL; Brahimi K; Daubersies P; Druilhe P
    Infect Immun; 2001 Feb; 69(2):1202-6. PubMed ID: 11160023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticle formulation enhanced protective immunity provoked by PYGPI8p-transamidase related protein (PyTAM) DNA vaccine in Plasmodium yoelii malaria model.
    Cherif MS; Shuaibu MN; Kodama Y; Kurosaki T; Helegbe GK; Kikuchi M; Ichinose A; Yanagi T; Sasaki H; Yui K; Tien NH; Karbwang J; Hirayama K
    Vaccine; 2014 Apr; 32(17):1998-2006. PubMed ID: 24440206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgenic Plasmodium that expresses HIV-1 Gag elicits immunity and protects mice against vaccinia virus-gag and malarial parasites.
    Jiang B; Qin L; Du Y; Peng N; Chen L; Chen Z; Chen X
    Vaccine; 2010 Nov; 28(50):7915-22. PubMed ID: 20933565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1.
    Hirunpetcharat C; Vukovic P; Liu XQ; Kaslow DC; Miller LH; Good MF
    J Immunol; 1999 Jun; 162(12):7309-14. PubMed ID: 10358180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice.
    Aly AS; Downie MJ; Mamoun CB; Kappe SH
    Cell Microbiol; 2010 Jul; 12(7):930-8. PubMed ID: 20088947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
    Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
    Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of nanoparticle coating on the immunogenicity of plasmid DNA vaccine encoding P. yoelii MSP-1 C-terminal.
    Shuaibu MN; Cherif MS; Kurosaki T; Helegbe GK; Kikuchi M; Yanagi T; Sasaki H; Hirayama K
    Vaccine; 2011 Apr; 29(17):3239-47. PubMed ID: 21354479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite.
    Kang Y; Calvo PA; Daly TM; Long CA
    J Immunol; 1998 Oct; 161(8):4211-9. PubMed ID: 9780195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active immunisation with RAMA does not provide protective immunity against Plasmodium yoelii challenge despite its association with protective responses in endemic populations.
    Kats LM; Wang L; Murhandarwati EE; Mitri K; Black CG; Coppel RL
    Vaccine; 2008 Jun; 26(26):3261-7. PubMed ID: 18468741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection.
    Petritus PM; Burns JM
    J Immunol; 2008 Jan; 180(1):444-53. PubMed ID: 18097046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
    Romero JF; Ibrahim GH; Renggli J; Himmelrich H; Graber P; Corradin G
    Parasite Immunol; 2007 Nov; 29(11):541-8. PubMed ID: 17944743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunity of peritoneal monocytes against Plasmodium yoelii infected erythrocytes].
    Mao YH; Yuan J; Liu BF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):415-7. PubMed ID: 15379267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect.
    Pouniotis DS; Proudfoot O; Bogdanoska V; Apostolopoulos V; Fifis T; Plebanski M
    Infect Immun; 2004 Sep; 72(9):5331-9. PubMed ID: 15322030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
    Rainczuk A; Scorza T; Spithill TW; Smooker PM
    Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross-protects A/J mice against challenge with P. c. adami DK and virulent Plasmodium chabaudi chabaudi AS parasites.
    Scorza T; Grubb K; Cambos M; Santamaria C; Tshikudi Malu D; Spithill TW
    Int J Parasitol; 2008 Jun; 38(7):819-27. PubMed ID: 18062974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmodium yoelii blood-stage antigens newly identified by immunoaffinity using purified IgG antibodies from malaria-resistant mice.
    Kamali AN; Marín-García P; Azcárate IG; Diez A; Puyet A; Bautista JM
    Immunobiology; 2012 Aug; 217(8):823-30. PubMed ID: 22658767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection and identification of malaria vaccine target molecule using bioinformatics and DNA vaccination.
    Shuaibu MN; Kikuchi M; Cherif MS; Helegbe GK; Yanagi T; Hirayama K
    Vaccine; 2010 Oct; 28(42):6868-75. PubMed ID: 20709002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.